Novo Nordisk A/S buy RudolfL
Start price
20.04.20
/
50%
€58.96
Target price
04.11.21
€90.00
Performance (%)
70.25%
End price
05.11.21
€100.38
Summary
This prediction ended on 05.11.21 with a price of €100.38. With a performance of 70.25% the BUY prediction by RudolfL was a big success. RudolfL has a follow-up prediction for Novo Nordisk A/S where he still thinks Novo Nordisk A/S is a Buy. Dividends of €6.84 are taken into consideration when calculating the performance. RudolfL has 50% into this predictionNovo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S | - | - | - | - |
| iShares Core DAX® | -1.670% | -1.001% | 10.864% | 12.563% |
| iShares Nasdaq 100 | -4.184% | -1.145% | 37.458% | 41.078% |
| iShares Nikkei 225® | -4.967% | -5.783% | 18.828% | 0.655% |
| iShares S&P 500 | -2.834% | -0.572% | 25.875% | 39.960% |
Comments by RudolfL for this prediction
In the thread Novo Nordisk A/S diskutieren
Kursziel geändert auf 90,0
In the thread Trading Novo Nordisk A/S
Die von RudolfL gewählte maximale Laufzeit wurde überschritten
Current prediction by RudolfL for Novo Nordisk A/S
Novo Nordisk A/S
Start price
Target price
Perf. (%)
€93.01
07.03.22
07.03.22
€195.00
18.07.24
18.07.24
109.54%
12.09.23
12.09.23
